LSH Acquires Seng Vital for Cannabis Opportunities
Filed with ASX · · 2 pages · English
Nexalis Therapeutics Limited on 6ix
Story so far
Earlier from Nexalis Therapeutics
- Lifespot Strengthens Go-To-Market Cannabis Strategy
- Update on Unique Cannabis Vaporiser launch and Bodytel
- LSH in discussions to finance integrated cannabis producers
- B.Braun to launch Omnitest 5 BT with Body-Tel
- Unique cannabis vaporizer under evaluation in Israel
Later from Nexalis Therapeutics
- First production completed for strong vape segment growth
- Commercial Sales and Distribution Agreement with CBDS Health
- Amended - Appendix 4C September 2018 Quarter
- Business Development focus in rapid growth Cannabis Category
- Lifespot signs Heads of agreement with IONIC brands
Follow Nexalis Therapeutics into a list and get an email when it puts out news.
Follow Nexalis Therapeutics